Sagimet Biosciences Inc.
SEC CIK 1400118 · SGMT · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Seidenberg Beth C | Director | filed 2023 - 2026 |
| Grammer Elizabeth A | Director | filed 2023 - 2026 |
| Hoelscher Paul W. | Director | filed 2024 - 2026 |
| Phillips Anne M. | Director | filed 2024 - 2026 |
| Jarrett Jennifer | Director | filed 2024 - 2026 |
| Kemble George | Director · Executive Chairman | filed 2023 - 2026 |
| Happel David | Director · President & CEO | filed 2023 - 2026 |
| Martins Eduardo Bruno | Director · Chief Medical Officer | filed 2023 - 2026 |
| Walbert Timothy P | Director | filed 2024 - 2025 |
| Parsey Merdad | Director | filed 2023 - 2024 |
| Rodgers Richard J | Director | filed 2023 - 2023 |
| Wu Jinzi Jason | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Grauer Andreas | Chief Medical Officer | filed 2026 - 2026 |
| Chauche Thierry | Chief Financial Officer | filed 2024 - 2026 |
| Rozek Elizabeth | General Counsel and CCO | filed 2023 - 2026 |
| Oriti Joseph | See Remarks | filed 2024 - 2024 |
| Hom Dennis | Chief Financial Officer | filed 2023 - 2023 |
| Rimac Anthony M | Chief Operating Officer | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.